Vincent Milano

Companies

• BioCryst PharmaceuticalsBoard member Jul 28, 2021 to now¹
• Aclaris Therapeutics, Inc.Board member Jan 9, 2020 to now²
• Idera SoftwareBoard member Dec 3, 2014 to Aug 11, 2023³
• Idera SoftwareChief executive officer Dec 3, 2014 to Jul 7, 2022³
• Idera SoftwarePresident Dec 3, 2014 to Jul 7, 2022³
• Vanda Pharmaceuticals Inc.Board member Apr 22, 2010 to Jun 15, 2018⁴
• ViroPharmaBoard member Jun 17, 2008 to Jan 28, 2014⁵
• ViroPharmaChief executive officer Jun 17, 2008 to Jan 28, 2014⁵
• ViroPharmaPresident Jun 17, 2008 to Jan 28, 2014⁵
• ViroPharmaChief financial officer Jan 19, 2006 to Jun 17, 2008⁶
• ViroPharmaChief operating officer Jan 19, 2006 to Jan 15, 2008⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• BioCryst Pharmaceuticals BCRX109,642 shares⁷$854.1K at $7.79Aug 31, 2026
• ATAclaris Therapeutics, Inc. ACRS28,896 shares⁸$94.8K at $3.28Jun 5, 2026
• Idera Software8,987 shares⁹Aug 10, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 31, 2026Granted 1,159 shares at $9.70 of BioCryst Pharmaceuticals⁷
• Jun 11, 2026Granted 15,294 shares of BioCryst Pharmaceuticals¹⁰
• Jun 5, 2026Exercised options 11,580 shares of Aclaris Therapeutics, Inc.⁸
• May 29, 2026Granted 1,122 shares at $8.91 of BioCryst Pharmaceuticals¹¹
• Feb 27, 2026Granted 848 shares at $8.75 of BioCryst Pharmaceuticals¹²
• Nov 28, 2025Granted 783 shares at $7.18 of BioCryst Pharmaceuticals¹³
• Aug 29, 2025Granted 676 shares at $8.31 of BioCryst Pharmaceuticals¹⁴
• Jun 12, 2025Granted 12,500 shares of BioCryst Pharmaceuticals¹⁵
• Jun 6, 2025Exercised options 4,793 shares of Aclaris Therapeutics, Inc.¹⁶
• May 30, 2025Granted 523 shares at $10.75 of BioCryst Pharmaceuticals¹⁷
• Feb 28, 2025Granted 653 shares at $8.61 of BioCryst Pharmaceuticals¹⁸
• Nov 29, 2024Granted 750 shares at $7.50 of BioCryst Pharmaceuticals¹⁹
• Aug 30, 2024Granted 647 shares at $8.69 of BioCryst Pharmaceuticals²⁰
• Jun 12, 2024Granted 6,820 shares of BioCryst Pharmaceuticals²¹
• Jun 1, 2024Exercised options 4,660 shares of Aclaris Therapeutics, Inc.²²
• May 31, 2024Granted 870 shares at $6.46 of BioCryst Pharmaceuticals²³
• May 20, 2024Bought 15,000 shares at $6.25 of BioCryst Pharmaceuticals²⁴
• Feb 29, 2024Granted 999 shares at $5.63 of BioCryst Pharmaceuticals²⁵
• Nov 30, 2023Granted 956 shares at $5.88 of BioCryst Pharmaceuticals²⁶
• Aug 31, 2023Granted 791 shares at $7.11 of BioCryst Pharmaceuticals²⁷
• Aug 10, 2023Sold 3,283 shares at $0.53 of Idera Software⁹
• Jun 13, 2023Granted 16,745 shares of BioCryst Pharmaceuticals²⁸
• Jun 2, 2023Exercised options 4,507 shares of Aclaris Therapeutics, Inc.²⁹
• May 31, 2023Granted 680 shares at $8.27 of BioCryst Pharmaceuticals³⁰
• Feb 28, 2023Granted 635 shares at $8.85 of BioCryst Pharmaceuticals³¹